Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|February 1, 1983
Influence of intracoronary platelet aggregation on ventricular electrical properties during partial coronary artery stenosisP R Kowey, R L Verrier, B Lown, et al.
The American Journal of Physiology|July 1, 1992
Catecholamines in cerebrospinal fluid are increased by behavioral arousal and myocardial ischemiaD A Johnson, J M Pinto, D A Kirby, et al.
Investigative Radiology|September 1, 1984
Postextrasystolic potentiation during spontaneous ventricular ectopy in man. Associated left ventricular volume changes determined by list mode radionuclide ventriculographyJ F Polak, B L Holman, P J Podrid, et al.
Science (New York, N.Y.)|February 13, 1981
Tyrosine administration decreases vulnerability to ventricular fibrillation in the normal canine heartN A Scott, R A DeSilva, B Lown, et al.
American Heart Journal|December 1, 1980
Cardioversion and defibrillationR A DeSilva, T B Graboys, P J Podrid, et al.
European Journal of Pharmacology|January 1, 1978
Effects of clonidine on vulnerability to fibrillation in the normal and ischemic canine ventricleF A Rotenberg, R L Verrier, B Lown, et al.
The American Journal of Cardiology|November 3, 1988
Combination antiarrhythmic therapy for management of malignant ventricular arrhythmiaM V Patt, C L Grossbard, T B Graboys, et al.
American Heart Journal|October 1, 1992
The prevalence of proarrhythmic events during moricizine therapy and their relationship to ventricular functionO Tschaidse, T B Graboys, B Lown, et al.
American Heart Journal|April 1, 1986
Relationship between ease of inducibility of arrhythmia with electrophysiologic testing and response to antiarrhythmic therapyF W Amann, C M Blatt, P J Podrid, et al.
American Heart Journal|May 1, 1986
The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmiaG Hirsowitz, P J Podrid, S Lampert, et al.
Pageof 15